Drugs / ABBV-990
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05475821 | Jul → Sep 2022 | — | AbbVie | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABBV-990 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05475821 ↗ |
| Route | Oral | “Participants will receive oral tablet of ABBV-990 or matching placebo on Day 1” NCT05475821 ↗ |